Medlock Amy E, Najahi-Missaoui Wided, Shiferaw Mesafint T, Albetel Angela N, Lanzilotta William N, Dailey Harry A
Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, U.S.A.
Augusta University/University of Georgia Medical Partnership, Athens, GA 30602, U.S.A.
Biochem J. 2021 Sep 17;478(17):3239-3252. doi: 10.1042/BCJ20210460.
Ferrochelatase catalyzes the insertion of ferrous iron into a porphyrin macrocycle to produce the essential cofactor, heme. In humans this enzyme not only catalyzes the terminal step, but also serves a regulatory step in the heme synthesis pathway. Over a dozen crystal structures of human ferrochelatase have been solved and many variants have been characterized kinetically. In addition, hydrogen deuterium exchange, resonance Raman, molecular dynamics, and high level quantum mechanic studies have added to our understanding of the catalytic cycle of the enzyme. However, an understanding of how the metal ion is delivered and the specific role that active site residues play in catalysis remain open questions. Data are consistent with metal binding and insertion occurring from the side opposite from where pyrrole proton abstraction takes place. To better understand iron delivery and binding as well as the role of conserved residues in the active site, we have constructed and characterized a series of enzyme variants. Crystallographic studies as well as rescue and kinetic analysis of variants were performed. Data from these studies are consistent with the M76 residue playing a role in active site metal binding and formation of a weak iron protein ligand being necessary for product release. Additionally, structural data support a role for E343 in proton abstraction and product release in coordination with a peptide loop composed of Q302, S303 and K304 that act a metal sensor.
亚铁螯合酶催化亚铁离子插入卟啉大环中,以产生必需的辅因子血红素。在人类中,这种酶不仅催化最后一步反应,还在血红素合成途径中起调节作用。人类亚铁螯合酶的十几个晶体结构已被解析,许多变体也已进行了动力学表征。此外,氢氘交换、共振拉曼光谱、分子动力学和高水平量子力学研究增进了我们对该酶催化循环的理解。然而,关于金属离子如何传递以及活性位点残基在催化中所起的具体作用仍未解决。数据表明金属结合和插入发生在与吡咯质子提取相反的一侧。为了更好地理解铁的传递和结合以及活性位点中保守残基的作用,我们构建并表征了一系列酶变体。进行了晶体学研究以及变体的挽救和动力学分析。这些研究的数据表明,M76残基在活性位点金属结合中起作用,并且形成弱铁蛋白配体对于产物释放是必要的。此外,结构数据支持E343在质子提取和产物释放中与由Q302、S303和K304组成的肽环协同作用,该肽环充当金属传感器。